Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: The impact of medication
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
MRI-based reports of both abnormally increased and decreased amygdala volume in bipolar disorder (BD) have surfaced in the literature. Two major methodological weaknesses characterizing extant studies are treatment with medication and inaccurate segmentation of the amygdala due to limitations in spatial and tissue contrast resolution. Here, we acquired high-resolution images (voxel size=0.55×0.55×0.60mm) using a GE 3T MRI scanner, and a pulse sequence optimized for tissue contrast resolution. The amygdala was manually segmented by one rater blind to diagnosis, using coronal images. Eighteen unmedicated (mean medication-free period 11±10 months) BD subjects were age and gender matched with 18 healthy controls, and 17 medicated (lithium or divalproex) subjects were matched to 17 different controls. The unmedicated BD patients displayed smaller left and right amygdala volumes than their matched control group (p<0.01). Conversely, the BD subjects undergoing medication treatment showed a trend towards greater amygdala volumes than their matched HC sample (p=0.051). Right and left amygdala volumes were larger (p<0.05) or trended larger, respectively, in the medicated BD sample compared with the unmedicated BD sample. The two control groups did not differ from each other in either left or right amygdala volume. BD patients treated with lithium have displayed increased gray matter volume of the cortex and hippocampus relative to untreated BD subjects in previous studies. Here we extend these results to the amygdala. We raise the possibility that neuroplastic changes in the amygdala associated with BD are moderated by some mood stabilizing medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
The amygdala: vigilance and emotion
Davis, M., & Whalen, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000812 · Cited by 2,882
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
The Amygdaloid Complex: Anatomy and Physiology
SAH, P., FABER, E. S. L., LOPEZ DE ARMENTIA, M., & POWER, J. (2003) · Physiological Reviews · doi:10.1152/physrev.00002.2003 · Cited by 1,745 · cited 2×
“Specifically, dysregulation of projections from the amygdala to the nucleus basalis, locus ceruleus, and ventral tegmental area (VTA) (Davis and Whalen, 2001; Sah et al., 2003) may alter cholinergic (ACh), noradrenergic (NE), and dopaminergic (DA) transmission, impacting mood and attention.”
BackgroundVyas, A., Mitra, R., Shankaranarayana Rao, B. S., & Chattarji, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06810.2002 · Cited by 1,662 · cited 1×
“Chronic, unpredictable stress in rodents has been reported to produce dendritic atrophy in the basolateral amygdala (BLA) (Vyas et al., 2002).”
BackgroundA meta-analysis of structural brain abnormalities in PTSD
KARL, A., SCHAEFER, M., MALTA, L., DORFEL, D., ROHLEDER, N., & WERNER, A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.03.004 · Cited by 881
Functional characteristics of the midbrain periaqueductal gray.
Behbehani, M. M. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00009-k · Cited by 879
Lithium-induced increase in human brain grey matter
Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., & Menji, H. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02793-8 · Cited by 649 · cited 4×
“Lithium, for instance, has been shown to increase whole brain GM volumes by 3% (24 ml) from baseline in BD patients treated for only 4 weeks (Moore et al., 2000); an effect that may extend to other mood stabilizers such as valproate (Mark et al.”
BackgroundResultInfluentialBipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
Savitz, J., & Drevets, W. C. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.01.004 · Cited by 494 · cited 2×
“, 2004), reducing the specificity and reliability of amygdala volumetric measures (Savitz and Drevets, 2009).”
BackgroundSelf-citationThe genetics of bipolar disorder
Barnett, J. H., & Smoller, J. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.080 · Cited by 407
An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia
Altshuler, L. L., Bartzokis, G., Grieder, T., Curran, J., Jimenez, T., Leight, K., Wilkins, J., Gerner, R., & Mintz, J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00836-2 · Cited by 369 · cited 4×
“Previous MRI studies of the amygdala either failed to control for medication effects (Altshuler et al., 2000; Frangou, 2005; Lyoo et al., 2004; Strakowski et al., 1999b; Velakoulis et al., 2006), or attempted to address this confound by comparing subjects receiving medication at the time of scanning against subjects n…”
BackgroundInfluentialMoskvina, V, Craddock, N., Holmans, P., Nikolov, I., Pahwa, J. S., Green, E., Wellcome Trust Case Control Consortium, Owen, M. J., & O'Donovan, M. C. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.133 · Cited by 363 · cited 1×
“In line with these data, some genetic studies are indicative of overlap in the risk variants for schizophrenia and BD (Barnett and Smoller, 2009; Lichtenstein et al., 2009; Moskvina et al., 2009), potentially suggesting a broader diathesis for psychotic breakdown.”
ResultYasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002099 · Cited by 358
Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder
Szeszko, P. R., Robinson, D., Alvir, J. M. J., Bilder, R. M., Lencz, T., Ashtari, M., Wu, H., & Bogerts, B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.913 · Cited by 346 · cited 1×
“Further, conditions such as OCD and PTSD,whichwere found in greater numbers in ourmedicated BD sample, have been associatedwith a reduction in amygdala volume (Szeszko et al., 1999; Karl et al., 2006) Since our medicated BD sample had larger amygdala volumes than non-medicated BD patients or healthy controls, this sug…”
ResultProlonged behavioral stress enhances synaptic connectivity in the basolateral amygdala
Vyas, A., Jadhav, S., & Chattarji, S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.003 · Cited by 299
Greater Cortical Gray Matter Density in Lithium-Treated Patients with Bipolar Disorder
Bearden, C. E., Thompson, P. M., Dalwani, M., Hayashi, K. M., Lee, A. D., Nicoletti, M., Trakhtenbroit, M., Glahn, D. C., Brambilla, P., Sassi, R. B., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.027 · Cited by 289
Frontal lobe gray matter density decreases in bipolar I disorder
Lyoo, I. K., Kim, M. J., Stoll, A. L., Demopulos, C. M., Parow, A. M., Dager, S. R., Friedman, S. D., Dunner, D. L., & Renshaw, P. F. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.017 · Cited by 263 · cited 3×
“Previous MRI studies of the amygdala either failed to control for medication effects (Altshuler et al., 2000; Frangou, 2005; Lyoo et al., 2004; Strakowski et al., 1999b; Velakoulis et al., 2006), or attempted to address this confound by comparing subjects receiving medication at the time of scanning against subjects n…”
BackgroundResultTaylor Tavares, J. V., Clark, L., Cannon, D. M., Erickson, K., Drevets, W. C., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.034 · Cited by 262
Self-citationMoore, G. J., Cortese, B. M., Glitz, D. A., Zajac-Benitez, C., Quiroz, J. A., Uhde, T. W., Drevets, W. C., & Manji, H. K. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m03745 · Cited by 234
Self-citationStructural plasticity and tianeptine: cellular and molecular targets
McEwen, B. S., Magarinos, A. M., & Reagan, L. P. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00650-8 · Cited by 108 · cited 1×
“Adrenal steroids appear to facilitate dendritic atrophy in rodents by increasing N-methyl-D-aspartate (NMDA) receptor signaling through the modulation of NMDA and GABA-A receptor gene expression, the activation of voltage-gated calcium channels, and a reduction in the expression of the glutamate transporter (McEwen et…”
Background
Cited by
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Self-citationNeural circuits underlying the pathophysiology of mood disorders
Price, J. L., & Drevets, W. C. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.12.011 · Cited by 788
Self-citationPotential Mechanisms of Action of Lithium in Bipolar Disorder: Current Understanding
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 453
Effects of medication on neuroimaging findings in bipolar disorder: an updated review
Hafeman, D. M., Chang, K. D., Garrett, A. S., Sanders, E. M., & Phillips, M. L. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01023.x · Cited by 379
Synaptic plasticity in depression: Molecular, cellular and functional correlates
Marsden, W. N. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.012 · Cited by 317
Metadata
- Authors
- Savitz, J., Nugent, A. C., Bogers, W., Liu, A., Sills, R., Luckenbaugh, D. A., Bain, E. E., Price, J. L., Zarate, C., Manji, H. K., Cannon, D. M., Marrett, S., Charney, D. S., & Drevets, W. C.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 49
- Issue
- 4
- Pages
- 2966-2976
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2080180365
- Cited by
- 108
- References
- 20
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.